Lasa Supergenerics Ltd.
Snapshot View

37.65 0.00

30 September 2022, 10:55:05 AM
Volume: 12,704

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lasalabs.com
Market Cap 153.34 Cr.
Enterprise Value(EV) 135.53 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -4.49 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 33.57 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.12 Calculated using Price: 37.70
Dividend Yield 0.66 Period Ending 2021-03
No. of Shares Subscribed 4.07 Cr. 40,672,668 Shares
FaceValue 10
Company Profile
The company is specialises in ‘catalyst chemistry' and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-6.69%
1 Month
+6.96%
3 Month
+46.50%
6 Month
-8.51%
1 Year
-51.17%
2 Year
-44.35%
5 Year
-70.90%
10 Year
6 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 8.65 14.33 -10.81 2.94 15.17
Return on Capital Employed (%) 14.45 12.80 -3.73 6.77 17.14
Return on Assets (%) 2.07 4.79 -4.44 1.50 10.43

Balance Sheet View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 0 75 117 105 141 159 149
Non Curr. Liab. 0 83 62 43 11 8 7
Curr. Liab. 70 107 107 76 41 44
Minority Int.
Equity & Liab. 0 228 287 255 229 208 199
Non Curr. Assets 149 178 170 153 144 127
Curr. Assets 0 79 109 86 76 64 72
Misc. Exp. not W/O 0
Total Assets 0 228 287 255 229 208 199

Profit Loss View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 199 244 170 167 202 130
Other Income 2 3 1 0 0 0
Total Income 201 247 170 167 203 130
Total Expenditure -153 -202 -159 -137 -155 -127
PBIDT 48 45 12 30 47 3
Interest -12 -11 -8 -8 -2 0
Depreciation -8 -18 -19 -17 -16 -14
Taxation 0 -3 4 -1 -7 0
Exceptional Items -26 -8
PAT 2 12 -12 4 23 -18
Adjusted EPS 472 5 -5 1 6 -4

Cash Flow View Details >>

Particulars 6 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 -3 40 41 14 41
Cash Fr. Inv. 0 -44 -7 -2 -4
Cash Fr. Finan. 0 0 4 -33 -10 -36
Net Change 0 -3 0 0 2 1
Cash & Cash Eqvt 0 0 1 0 3 4

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 64.47 64.47 64.47 64.47 64.47 64.47 45.01 43.78 43.78
Public 35.53 35.53 35.53 35.53 35.53 35.53 54.99 56.22 56.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 43.23 35.15 31.19

Announcements View Details >>

Thu, 29 Sep 2022
Annual General Meeting
Lasa Supergenerics Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 26-Sep-2022
Wed, 28 Sep 2022
Annual General Meeting
Lasa Supergenerics Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 26-Sep-2022
Tue, 27 Sep 2022
Annual General Meeting
Lasa Supergenerics Limited has informed the Exchange about Proceedings of Annual General Meeting held on 26-Sep-2022

Technical Scans View Details >>

Thu, 29 Sep 2022
Opening at High Opening at High
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
Closing Near 100 SMA Closing Near 100 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 933.30 +0.3%
Divi's Laboratories Ltd. 97,819.86 3,666.35 -0.7%
Cipla Ltd. 90,339.79 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. 52,359.20 1,536.05 -0.6%
Abbott India Ltd. 40,610.60 18,900.15 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-06 36.30 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-06 50.22 18,900.15 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-06 4.20 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-06 13.62 18,900.15 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-03 0.00 18,900.15 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-03 29.95 18,900.15 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-03 29.95 18,900.15 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,900.15 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 933.30 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,666.35 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,106.30 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,287.80 -1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,418.45 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,536.05 -0.6%
Abbott India Ltd. Standalone 2022-03 798.70 18,900.15 -1.5%

FAQ's On Lasa Supergenerics Ltd.

What is Lasa Supergenerics share price?

Can I buy Lasa Supergenerics shares now?

What is the Dividend Yield of Lasa Supergenerics?

What is the Market Cap of Lasa Supergenerics?

What are the key metrics to analyse Lasa Supergenerics?

What is the 52 Week High and Low of Lasa Supergenerics?

What is the trend of Lasa Supergenerics share price?